Goldman Sachs’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Sell |
|
|||||
|
2025
Q1 | $5.74M | Sell |
|
|||||
|
2024
Q4 | $16.1M | Sell |
|
|||||
|
2024
Q3 | $27.8M | Sell |
|
|||||
|
2024
Q2 | $31.4M | Buy |
|
|||||
|
2024
Q1 | $25.9M | Buy |
|
|||||
|
2023
Q4 | $609K | Sell |
|
|||||
|
2023
Q3 | $536K | Buy |
|
|||||
|
2023
Q2 | $423K | Sell |
|
|||||
|
2023
Q1 | $801K | Buy |
|
|||||
|
2022
Q4 | $465K | Buy |
|
|||||
|
2022
Q3 | $195K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $151K | Sell |
|
|||||
|
2021
Q2 | $141K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $29K | Sell |
|
|||||
|
2019
Q4 | $53K | Sell |
|
|||||
|
2019
Q3 | $225K | Sell |
|
|||||
|
2019
Q2 | $817K | Buy |
|
|||||
|
2019
Q1 | $556K | Sell |
|
|||||
|
2018
Q4 | $1.05M | Buy |
|
|||||
|
2018
Q3 | $1.89M | Buy |
|
|||||
|
2018
Q2 | $629K | Sell |
|
|||||
|
2018
Q1 | $1.22M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $42K | Sell |
|
|||||
|
2017
Q2 | $692K | Buy |
|
|||||
|
2017
Q1 | $51K | Sell |
|
|||||
|
2016
Q4 | $99K | Buy |
|
|||||
|
2016
Q3 | $102K | Buy |
|
|||||
|
2016
Q2 | $97K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $339K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $4.87M | Buy |
|
|||||
|
2015
Q1 | $888K | Sell |
|
|||||
|
2014
Q4 | $1.86M | Sell |
|
|||||
|
2014
Q3 | $1.29M | Buy |
|